Friday, July 31, 2026

Is Denuclearization Possible? President Lee’s Bold Vision for North Korea Relations in 2026

President Lee Jae Myung emphasizes a realistic approach to North Korea's denuclearization while acknowledging ongoing challenges and concerns.

How U.S. and Israel’s Airstrikes on Iran Could Impact North Korea’s Diplomatic Stance

NIS warns North Korea may hesitate to engage in dialogue due to U.S. and Israeli airstrikes on Iran, affecting Korean nationals abroad.

IU Takes Legal Action: How a U.S. Court Could Unmask Malicious Trolls

IU takes legal action in the U.S. to uncover online detractors spreading false rumors and defamation against her.

Tag: chemotherapy

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

“We Treat Patients’ Lives, Not Just Cancer” — The Future of Cancer Care Led by a Breast Cancer Pioneer [K-Medical Report]

A compassionate approach to cancer treatment, emphasizing emotional support and tailored care, leads to high survival rates and patient satisfaction.

Boryung Begins First Global CDMO Supply of Alimta Through Taiwan Partnership

Boryung Pharmaceutical starts supplying Alimta to Lotus, enhancing global CDMO efforts and addressing chemotherapy drug shortages.

A New Study Suggests Selenium Could Help With One of Chemotherapy’s Most Disruptive Side Effects

A study reveals high-dose selenium can reduce exercise-related dysfunction in ovarian cancer patients undergoing chemotherapy.

FDA Approval Allows AlphaTau to Broaden IMPACT Trial in Pancreatic Cancer

AlphaTau Medical expands its pancreatic cancer trial with FDA approval, adding 10 patients for a combination treatment approach.

Tailored Chemotherapy Boosts Survival Rates for Elderly Colon Cancer Patients

A study reveals tailored treatment for elderly colon cancer patients boosts survival rates, challenging age-based treatment limitations.

Unlocking Triple Negative Breast Cancer: How Gene-Protein Analysis Predicts Treatment Success

A study reveals that analyzing genetic and protein data can predict chemotherapy effectiveness in triple-negative breast cancer, aiding personalized treatment.

Unlocking Convenience: Rolvedon’s Same-Day Chemotherapy Solution for Neutropenia Revealed

Hanmi Pharmaceutical's Rolvedon shows potential for same-day chemotherapy administration, improving patient convenience and market competitiveness.

Opdivo Wins EU Approval in Big Step for Early Lung Cancer Treatment

Opdivo gains EU approval for perioperative therapy in NSCLC, enhancing competition with Keytruda and marking a treatment paradigm shift.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.